¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"total hyperplasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pseudocarcinomatous hyperplasia
    °ÅÁþ¾ÏÁ¾Áõ½Ä
  • pseudoepitheliomatous hyperplasia
    °ÅÁþ»óÇÇÁ¾Áõ½Ä
  • reactive nodular hyperplasia
    ¹ÝÀÀ¼º°áÀýÁõ½Ä
  • syringolymphoid hyperplasia
    ¶¡»ù°ü¸²ÇÁ¸ð¾çÁõ½Ä, ÇѰü¸²ÇÁ¼¼Æ÷Áõ½ÄÁõ
  • sebaceous hyperplasia
    ÇÇÁö»ùÁõ½Ä, ÇǺα⸧»ùÁõ½Ä
  • simple hyperplasia
    ´Ü¼øÁõ½Ä
  • verrucous hyperplasia
    »ç¸¶±Í¸ð¾çÁõ½Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • total albinism
    ¿Â¹é»öÁõ
  • total ankylosis
    ¿ÏÀü°­Á÷, ¿ÏÀü°üÀý±»À½Áõ
  • total anodontia
    ¿ÏÀü¹«Ä¡¾ÆÁõ
  • total aphasia
    (¢¡global aphasia) ¿ÏÀü¾ð¾î»ó½ÇÁõ
  • total blindness
    ¿ÏÀü½Ã°¢»ó½Ç, ¿ÏÀü½Ç¸í
  • total color blindness
    ¿ÏÀü»ö°¢»ó½Ç, ¿ÏÀü»ö¸Í
  • total cataract
    ¿ÏÀü¹é³»Àå
  • total cleavage
    (¢¡holoblastic cleavage) ¿ÂºÐÇÒ, ÀüüºÐÇÒ
  • total cystectomy
    ¹æ±¤¸ðµÎÀýÁ¦¼ú
  • total bacterial count
    Ãѱռö
  • total lung capacity
    ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
  • total organic carbon
    ÃÑÀ¯±âź¼Ò
  • total deafness
    ¿ÏÀü±Í¸ÔÀ½
  • total oxygen demand
    ¿Â»ê¼Ò¿ä±¸·®
  • total potential energy difference
    ÃÑÀ§Ä¡¿¡³ÊÁöÂ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • follicular hyperplasia
    ¸ð³¶ Áõ½Ä(¡­ñòãÖ)
  • gingival hyperplasia
    Ä¡ÀºÁõ½Ä(Áõ)(öÍó»ñòãÖñø).
  • hyperplasia
    Áõ½Ä
  • hyperplasia
    °ú´ÙÇü¼º
  • hyperplasia endometrii glandularis ³ª
    ¼±¼ºÀڱ󻸷Áõ½Ä(Áõ)(àÍàõí­ÏàҮد ñòãÖñø).
  • hyperplasia of adrenal gland
    ºÎ½Å¼±Áõ½Ä
  • hyperplasia,atypical
    ºñÁ¤Çü(ÞªïÒû¡)
  • hyperplasia,compensatory
    ´ë»ó¼º
  • intravascular papillary endothelial hyperplasia
    Ç÷°ü³» À¯µÎ¾ç ³»ÇǼ¼Æ÷ Áõ½ÄÁõ
  • lentiginous melanocytic hyperplasia
    ÈæÀÚ¼º ¸á¶ó´Ñ¼¼Æ÷Áõ½Ä
  • leukoblastic hyperplasia
    ¹é¸ð±¸°úÇü¼º (??Ì´ËÛ).
  • lymphoid hyperplasia
    ¸²ÇÁ¾çÁõ½Ä(Áõ)(¡­ñòãÖñø)
  • nodular hyperplasia
    °áÀý¼º °úÇü¼º(~°úÇü¼º).
  • nodular hyperplasia
    ¼Ò°áÀý¼º °úÇü¼º(᳡­ Φû¡à÷)
  • nodular hyperplasia
    °áÀý¼º °ú´Ù Çü¼º(Ì¿ï½àõΦÒýû¡à÷), ¼Ò °áÀý¼º °úÇü¼º(~Φû¡à÷).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TRC tanned red cell; therapeutic residential center; total renin concentration; total respiratory conduc...
BPH Benign Prostate(Prostatic) Hypertrophy(Hyperplasia); Àü¸³¼± ºñ´ë(Áõ)
CAH   1) Chronic Active Hepatitis
  2) Congenital Adrenal Hyperplasia
AFH angiofollicular hyperplasia; anterior facial height
AFLNH angiofollicular lymph node hyperplasia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CAH Cogenital adrenal hyperplasia
CLH Cutaneous lymphoid hyperplasia
EH Endometrial hyperplasia
FNH Focal Nodular Hyperplasia
FEH Focal epithelial hyperplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • total body opacification
    Àü½Å ºÒÅõ¸íÈ­
  • total care
    Àü½Å Ä¡·á
  • total color blindness
    ¿ÏÀü »ö¸Í
  • total count of bacteria
    ÃÑ±Õ ¼ö °èÃø
  • total cystectomy
    ¹æ±¤Àü ÀûÃâ¼ú
  • total dose
    Àü·®, ÃѼ±·®
  • total elasticity of muscle
    ±ÙÀ° ÃÑ Åº¼º
  • total extirpation
    Àü ÀûÃâ, Àü ÀûÃâ¼ú
  • total fatty acids
    ÃÑ Áö¹æ»ê
  • total flow
    ÃÑ À¯·®, Àüü À¯·®
  • total gastrectomy
    À§ ÀüÀýÁ¦, À§ ÀüÀýÁ¦¼ú
  • total growth
    ÃÑ Áõ½Ä·®
  • total hematuria
    Àü Ç÷´¢Áõ
  • total hysterectomy
    Àü Àڱà ÀýÁ¦¼ú
  • total inversion
    Àüü ÀÚ¸®¹Ù²Þ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
intravascular papillary endothelial hyperplasia A benign florid papillary endothelial proliferation within the veins of the skin or subcutis, less often in visceral blood vessels.
Synonym: Masson's pseudoangiosarcoma.
(05 Mar 2000)
thymus hyperplasia Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis.
(12 Dec 1998)
endometrial hyperplasia <gynaecology, pathology> Thickening of the endometrial lining due to an overgrowth of mucosal cells.
Symptoms often include irregular vaginal bleeding, heavy or prolonged menstrual cycles and post-menopausal bleeding in older women.
Origin: Gr. Plassein = to form
(07 Apr 1998)
transmissible murine colonic hyperplasia A disease of young mice caused by the bacterium Citrobacter freundii and characterised by diarrhoea and mucosal hyperplasia of the descending colon.
(05 Mar 2000)
fibromuscular hyperplasia Thickening of arterial media by fibrosis and muscular hyperplasia, usually involving the renal arteries and causing multifocal stenosis and hypertension; a variety of fibromuscular dysplasia.
(05 Mar 2000)
focal epithelial hyperplasia Hyperplasia of the mucous membrane of the lips, tongue, and less commonly, the buccal mucosa, floor of the mouth, and palate, presenting soft, painless, round to oval sessile papules about 1 to 4 mm in diameter. The condition usually occurs in children and young adults and has familial predilection, lasting for several months, sometimes years, before running its course. A viral aetiology is suspected, the isolated organism being usually the human papilloma virus.
(12 Dec 1998)
focal nodular hyperplasia <radiology> Focal nodules of normal hepatocytes, Kuppfer cells and bile ducts, F more than M, rare, benign, multiple in 20%, haemorrhage (most common complication) in only 2-3% (unlike hepatic adenoma), stellate fibrous septae (stellate scar), NM: normal or increased uptake on HIDA and sulfur colloid
(12 Dec 1998)
radical mastectomy, total Breast cancer treatment involving removal of the breast, the pectoral (chest) muscles, lymph nodes (the glands ) in the armpit and associated skin and subcutaneous tissue.
(12 Dec 1998)
parenteral nutrition, home total The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route.
(12 Dec 1998)
parenteral nutrition, total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of tpn solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins.
(12 Dec 1998)
reversal of organs, total This condition (medically called situs inversus totalis) involves complete transposition (right to left reversal) of the thoracic and abdominal organs. The heart is not in its usual position in the left chest but is on the right. Specifically related to the heart, this is referred to as dextrocardia (literally, right-hearted). And the stomach, which is normally in the left upper abdomen, is on the right. In patients with situs inversus totalis, all of the chest and abdominal organs are reversed and appear in mirror image when examined or visualised by tests such as X-ray filming. Situs inversus totalis has been estimated to occur once in about 6-8,000 births. Situs inversus occurs in a rare abnormal condition that is present at birth (congenital) called kartagener's syndrome.
(12 Dec 1998)
communication methods, total Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication.
(12 Dec 1998)
congenital total lipodystrophy Lipodystrophy characterised by almost complete lack of subcutaneous fat, accelerated rate of growth and skeletal development during the first 3 to 4 years of life, muscular hypertrophy, cardiac enlargement, hepatosplenomegaly, hypertrichosis, renal enlargement, hypertriglyceridemia, and hypermetabolism; both autosomal dominant and X-linked varieties exist.
(05 Mar 2000)
hysterectomy, total Complete surgical removal of the uterus and cervix. Also called a complete hysterectomy.
(12 Dec 1998)
near-total thyroidectomy Removal of nearly all of each thyroid lobe leaving unresected only a small portion of gland adjacent to the entrance of the recurrent laryngeal nerve into the larynx.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á